Preparation, characterization, and hypoglycemic effect of chickpea saponin microcapsules encapsulated with modified chickpea protein
International Journal of Biological Macromolecules · 2025
DOI: 10.1016/j.ijbiomac.2025.148317 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Biological Macromolecules, 2025. Verfasst von Liyun Deng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Ya'an People's Hospital, Ya'an City, Sichuan Province, 625000, China. Hauptthemen laut MEDLINE: Cicer, Saponins, Hypoglycemic Agents, Plant Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Chengdu Medical College.
Abstract (Originalsprache)
Chickpea saponins exhibit hypoglycemic activity, yet their bitter taste and low bioavailability have restricted practical applications. Microencapsulation technology, however, can mask undesirable flavors and enable targeted sustained release in the intestine, thereby enhancing the bioavailability of chickpea saponins. In this study, chickpea saponin microcapsules (CSMs) were prepared via complex coacervation, utilizing modified chickpea protein and gum arabic as composite wall materials. The encapsulation efficiency, drug loading capacity, and average particle size of the CSMs were determined to be 76.84 ± 0.06 %, 100.42 mg/g, and 342.0 nm, respectively, with each experiment performed in triplicate. The CSMs showed remarkable sustained-release behavior in simulated saliva, gastric fluid, and intestinal fluid, with maximum cumulative release rates of 12.23 ± 0.26 %, 36.15 ± 3.72 %, and 85.09 ± 1.45 %, respectively. Scanning electron microscopy (SEM) observations revealed that the CSMs possessed a dense spherical structure, indicating effective encapsulation of chickpea saponins. Furthermore, the maximum heat-resistant temperature of the CSMs was 55 °C higher than that of raw chickpea saponins, reflecting enhanced thermal stability. Animal experiments confirmed that the CSMs exerted stronger in vivo biological effects and thus exhibited superior hypoglycemic activity compared to unencapsulated chickpea saponins in diabetic mice. These findings demonstrate that microencapsulation technology is a promising strategy for improving the in vivo biological efficacy of chickpea saponins, thereby expanding their potential applications in functional foods.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Ya'an People's Hospital, Ya'an City, Sichuan Province, 625000, China.
- Department of Food Nutrition, School of Laboratory Medicine, Chengdu Medical College, Chengdu, 610500, China.
- Department of Food Nutrition, School of Laboratory Medicine, Chengdu Medical College, Chengdu, 610500, China; Sichuan Provincial Engineering Laboratory for Prevention and Control Technology of Veterinary Drug Residue in…
Förderung
- Chengdu Medical College
Zitieren
APA
Deng, L., Chai, T., Li, L., Xu, H., Zhou, L., Qiu, Y., Ning, J., & Jiang, Y. (2025). Preparation, characterization, and hypoglycemic effect of chickpea saponin microcapsules encapsulated with modified chickpea protein. International Journal of Biological Macromolecules. https://doi.org/10.1016/j.ijbiomac.2025.148317
Vancouver
Deng L, Chai T, Li L, Xu H, Zhou L, Qiu Y, et al. Preparation, characterization, and hypoglycemic effect of chickpea saponin microcapsules encapsulated with modified chickpea protein. International Journal of Biological Macromolecules. 2025. doi:10.1016/j.ijbiomac.2025.148317
BibTeX
@article{Deng2025,
author = {Deng, Liyun and Chai, Tao and Li, Liang and Xu, Han and Zhou, Li and Qiu, Yue and Ning, Junli and Jiang, Yan},
title = {Preparation, characterization, and hypoglycemic effect of chickpea saponin microcapsules encapsulated with modified chickpea protein},
journal = {International Journal of Biological Macromolecules},
year = {2025},
doi = {10.1016/j.ijbiomac.2025.148317}
}
EUVIMED